These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 29421274)

  • 1. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.
    Sereni L; Castiello MC; Marangoni F; Anselmo A; di Silvestre D; Motta S; Draghici E; Mantero S; Thrasher AJ; Giliani S; Aiuti A; Mauri P; Notarangelo LD; Bosticardo M; Villa A
    J Allergy Clin Immunol; 2018 Oct; 142(4):1272-1284. PubMed ID: 29421274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
    Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
    Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet antibodies in WASP(-) mice correlate with evidence of increased in vivo platelet consumption.
    Marathe BM; Prislovsky A; Astrakhan A; Rawlings DJ; Wan JY; Strom TS
    Exp Hematol; 2009 Nov; 37(11):1353-63. PubMed ID: 19733207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Wiskott-Aldrich Syndrome Protein Deficiency on IL-10-Producing Regulatory B Cells in Humans and Mice.
    Du HQ; Zhang X; An YF; Ding Y; Zhao XD
    Scand J Immunol; 2015 Jun; 81(6):483-93. PubMed ID: 25728049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WASP plays a novel role in regulating platelet responses dependent on alphaIIbbeta3 integrin outside-in signalling.
    Shcherbina A; Cooley J; Lutskiy MI; Benarafa C; Gilbert GE; Remold-O'Donnell E
    Br J Haematol; 2010 Feb; 148(3):416-27. PubMed ID: 19863535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid platelet turnover in WASP(-) mice correlates with increased ex vivo phagocytosis of opsonized WASP(-) platelets.
    Prislovsky A; Marathe B; Hosni A; Bolen AL; Nimmerjahn F; Jackson CW; Weiman D; Strom TS
    Exp Hematol; 2008 May; 36(5):609-23. PubMed ID: 18346836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome.
    Wang C; Sample KM; Gajendran B; Kapranov P; Liu W; Hu A; Zacksenhaus E; Li Y; Hao X; Ben-David Y
    Front Immunol; 2021; 12():607836. PubMed ID: 33717090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome.
    Adriani M; Aoki J; Horai R; Thornton AM; Konno A; Kirby M; Anderson SM; Siegel RM; Candotti F; Schwartzberg PL
    Clin Immunol; 2007 Jul; 124(1):41-8. PubMed ID: 17512803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction.
    Shcherbina A; Rosen FS; Remold-O'Donnell E
    J Immunol; 1999 Dec; 163(11):6314-20. PubMed ID: 10570326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.
    Haddad E; Cramer E; Rivière C; Rameau P; Louache F; Guichard J; Nelson DL; Fischer A; Vainchenker W; Debili N
    Blood; 1999 Jul; 94(2):509-18. PubMed ID: 10397718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency.
    Lang PA; Shaabani N; Borkens S; Honke N; Scheu S; Booth S; Brenner D; Meryk A; Barthuber C; Recher M; Mak TW; Ohashi PS; Häussinger D; Griffiths GM; Thrasher AJ; Bouma G; Lang KS
    J Allergy Clin Immunol; 2013 Mar; 131(3):815-24. PubMed ID: 23141740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans.
    Castiello MC; Bosticardo M; Pala F; Catucci M; Chamberlain N; van Zelm MC; Driessen GJ; Pac M; Bernatowska E; Scaramuzza S; Aiuti A; Sauer AV; Traggiai E; Meffre E; Villa A; van der Burg M
    J Autoimmun; 2014 May; 50(100):42-50. PubMed ID: 24369837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets from WAS patients show an increased susceptibility to ex vivo phagocytosis.
    Prislovsky A; Zeng X; Sokolic RA; Garabedian EN; Anur P; Candotti F; Strom TS
    Platelets; 2013; 24(4):288-96. PubMed ID: 22812495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome.
    Sereni L; Castiello MC; Di Silvestre D; Della Valle P; Brombin C; Ferrua F; Cicalese MP; Pozzi L; Migliavacca M; Bernardo ME; Pignata C; Farah R; Notarangelo LD; Marcus N; Cattaneo L; Spinelli M; Giannelli S; Bosticardo M; van Rossem K; D'Angelo A; Aiuti A; Mauri P; Villa A
    J Allergy Clin Immunol; 2019 Sep; 144(3):825-838. PubMed ID: 30926529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-WASP is required for B-cell-mediated autoimmunity in Wiskott-Aldrich syndrome.
    Volpi S; Santori E; Abernethy K; Mizui M; Dahlberg CI; Recher M; Capuder K; Csizmadia E; Ryan D; Mathew D; Tsokos GC; Snapper S; Westerberg LS; Thrasher AJ; Candotti F; Notarangelo LD
    Blood; 2016 Jan; 127(2):216-20. PubMed ID: 26468226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets in Wiskott-Aldrich syndrome: Victims or executioners?
    Sereni L; Castiello MC; Villa A
    J Leukoc Biol; 2018 Mar; 103(3):577-590. PubMed ID: 28851742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation.
    Snapper SB; Rosen FS; Mizoguchi E; Cohen P; Khan W; Liu CH; Hagemann TL; Kwan SP; Ferrini R; Davidson L; Bhan AK; Alt FW
    Immunity; 1998 Jul; 9(1):81-91. PubMed ID: 9697838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis.
    Humblet-Baron S; Sather B; Anover S; Becker-Herman S; Kasprowicz DJ; Khim S; Nguyen T; Hudkins-Loya K; Alpers CE; Ziegler SF; Ochs H; Torgerson T; Campbell DJ; Rawlings DJ
    J Clin Invest; 2007 Feb; 117(2):407-18. PubMed ID: 17218989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.
    Zhang J; Shehabeldin A; da Cruz LA; Butler J; Somani AK; McGavin M; Kozieradzki I; dos Santos AO; Nagy A; Grinstein S; Penninger JM; Siminovitch KA
    J Exp Med; 1999 Nov; 190(9):1329-42. PubMed ID: 10544204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.